These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15888489)

  • 1. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.
    Chung CY; Seo H; Sonntag KC; Brooks A; Lin L; Isacson O
    Hum Mol Genet; 2005 Jul; 14(13):1709-25. PubMed ID: 15888489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
    Fonck C; Baudry M
    Brain Res; 2001 Jun; 905(1-2):199-206. PubMed ID: 11423095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study.
    Wang J; Xu Z; Fang H; Duhart HM; Patterson TA; Ali SF
    Neurotoxicology; 2007 Sep; 28(5):979-87. PubMed ID: 17475336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins.
    Lee MA; Lee HS; Lee HS; Cho KG; Jin BK; Sohn S; Lee YS; Ichinose H; Kim SU
    Neurosci Lett; 2002 Nov; 333(1):74-8. PubMed ID: 12401563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells.
    Chu CT; Zhu JH; Cao G; Signore A; Wang S; Chen J
    J Neurochem; 2005 Sep; 94(6):1685-95. PubMed ID: 16156740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
    German DC; Manaye KF; Sonsalla PK; Brooks BA
    Ann N Y Acad Sci; 1992 May; 648():42-62. PubMed ID: 1353337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
    Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
    Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.
    Kostuk EW; Cai J; Iacovitti L
    J Neuroinflammation; 2018 May; 15(1):139. PubMed ID: 29751760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro.
    Huang JY; Hong YT; Chuang JI
    J Neurochem; 2009 Jun; 109(5):1400-12. PubMed ID: 19476551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D; Unsicker K
    J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons.
    Chung CY; Licznerski P; Alavian KN; Simeone A; Lin Z; Martin E; Vance J; Isacson O
    Brain; 2010 Jul; 133(Pt 7):2022-31. PubMed ID: 20573704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease.
    Chung CY; Koprich JB; Endo S; Isacson O
    J Neurosci; 2007 Aug; 27(31):8314-23. PubMed ID: 17670978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
    Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T
    Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesencephalic dopaminergic neurons express a repertoire of olfactory receptors and respond to odorant-like molecules.
    Grison A; Zucchelli S; Urzì A; Zamparo I; Lazarevic D; Pascarella G; Roncaglia P; Giorgetti A; Garcia-Esparcia P; Vlachouli C; Simone R; Persichetti F; Forrest AR; Hayashizaki Y; Carloni P; Ferrer I; Lodovichi C; Plessy C; ; Carninci P; Gustincich S
    BMC Genomics; 2014 Aug; 15(1):729. PubMed ID: 25164183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures.
    Friedman LK; Mytilineou C
    J Pharmacol Exp Ther; 1990 May; 253(2):892-8. PubMed ID: 2338661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.
    Lu L; Neff F; Fischer DA; Henze C; Hirsch EC; Oertel WH; Schlegel J; Hartmann A
    Neurobiol Dis; 2006 Aug; 23(2):409-21. PubMed ID: 16753304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nurr1 and PPARγ protect PC12 cells against MPP(+) toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairment.
    Jodeiri Farshbaf M; Forouzanfar M; Ghaedi K; Kiani-Esfahani A; Peymani M; Shoaraye Nejati A; Izadi T; Karbalaie K; Noorbakhshnia M; Rahgozar S; Baharvand H; Nasr-Esfahani MH
    Mol Cell Biochem; 2016 Sep; 420(1-2):29-42. PubMed ID: 27435855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress.
    Hsieh YC; Mounsey RB; Teismann P
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):157-67. PubMed ID: 21667279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
    Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F
    Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.